Your browser is no longer supported. Please, upgrade your browser.
Settings
TECH Bio-Techne Corporation daily Stock Chart
TECH [NASD]
Bio-Techne Corporation
Index- P/E38.07 EPS (ttm)4.96 Insider Own0.50% Shs Outstand38.88M Perf Week-8.32%
Market Cap7.34B Forward P/E33.49 EPS next Y5.64 Insider Trans-38.46% Shs Float38.16M Perf Month-13.17%
Income195.10M PEG3.46 EPS next Q1.29 Inst Own94.80% Short Float1.27% Perf Quarter-14.14%
Sales744.70M P/S9.86 EPS this Y1.10% Inst Trans-1.02% Short Ratio3.26 Perf Half Y-0.90%
Book/sh34.67 P/B5.45 EPS next Y15.97% ROA10.20% Target Price237.88 Perf Year-2.58%
Cash/sh6.28 P/C30.10 EPS next 5Y11.00% ROE16.20% 52W Range178.28 - 223.29 Perf YTD-13.95%
Dividend1.28 P/FCF63.15 EPS past 5Y-3.80% ROI6.90% 52W High-15.41% Beta1.23
Dividend %0.68% Quick Ratio3.50 Sales past 5Y14.80% Gross Margin66.20% 52W Low5.95% ATR6.14
Employees2250 Current Ratio4.40 Sales Q/Q6.00% Oper. Margin21.20% RSI (14)24.13 Volatility3.67% 3.12%
OptionableYes Debt/Eq0.29 EPS Q/Q567.60% Profit Margin26.20% Rel Volume2.62 Prev Close193.01
ShortableYes LT Debt/Eq0.28 EarningsFeb 04 BMO Payout25.00% Avg Volume148.81K Price188.89
Recom1.70 SMA20-7.94% SMA50-11.32% SMA200-8.41% Volume389,991 Change-2.13%
Jan-08-20Resumed Stephens Overweight $250
Jan-08-20Initiated Wells Fargo Equal Weight $230
Jan-07-20Initiated Citigroup Neutral $235
Nov-15-19Initiated Stifel Buy
Jul-02-19Upgrade Janney Neutral → Buy $200 → $270
Jan-14-19Upgrade Stephens Equal-Weight → Overweight
Oct-31-18Downgrade Craig Hallum Buy → Hold
Oct-17-18Initiated Goldman Neutral $190
Jun-15-18Initiated Argus Buy $185
Jul-13-17Initiated Wells Fargo Market Perform
Feb-09-17Initiated Citigroup Buy $115
Jan-18-17Initiated Deutsche Bank Buy $115
Nov-10-16Resumed Leerink Partners Outperform $122
Jan-21-15Reiterated Robert W. Baird Outperform $102 → $104
Sep-20-13Upgrade Robert W. Baird Neutral → Outperform $76 → $90
Jun-08-12Initiated William Blair Mkt Perform
Feb-01-12Downgrade Robert W. Baird Outperform → Neutral $81 → $71
Feb-04-09Upgrade Robert W. Baird Neutral → Outperform $76 → $69
Feb-04-09Reiterated Leerink Swann Outperform $73.50 → $59.50
Oct-13-08Upgrade Leerink Swann Mkt Perform → Outperform
Feb-24-20 07:00AM  Bio-Techne To Present At The Cowen 40th Annual Health Care Conference PR Newswire
Feb-17-20 07:00AM  Bio-Techne To Present At The SVB Leerink 9th Annual Global Healthcare Conference PR Newswire
Feb-10-20 02:39AM  Edited Transcript of TECH earnings conference call or presentation 4-Feb-20 2:00pm GMT Thomson Reuters StreetEvents
Feb-06-20 02:14PM  Should You Take Comfort From Insider Transactions At Bio-Techne Corporation (NASDAQ:TECH)? Simply Wall St.
Feb-05-20 07:00AM  Bio-Techne Announces Availability Of Next Generation ELISA Kits PR Newswire
Feb-04-20 07:55AM  Techne (TECH) Lags Q2 Earnings and Revenue Estimates Zacks
07:00AM  Bio-Techne Corp. to Host Earnings Call ACCESSWIRE
06:30AM  Bio-Techne Releases Second Quarter Fiscal 2020 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Jan-28-20 12:31PM  Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Jan-21-20 08:30AM  Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies Business Wire
Jan-09-20 07:00AM  Bio-Techne To Host Conference Call On February 4, 2020 To Announce Second Quarter 2020 Financial Results PR Newswire
Jan-07-20 07:00AM  Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product Portfolio PR Newswire
Jan-02-20 07:00AM  Bio-Techne To Present At The 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-01-20 11:40AM  GILD vs. TECH: Which Stock Should Value Investors Buy Now? Zacks
Dec-23-19 01:10PM  Based On Its ROE, Is Bio-Techne Corporation (NASDAQ:TECH) A High Quality Stock? Simply Wall St.
Dec-21-19 07:21PM  Is Bio-Techne Corporation (TECH) A Good Stock To Buy? Insider Monkey
Dec-17-19 07:00AM  Bio-Techne's Exosome Diagnostics Lab Receives Accreditation From College of American Pathologists (CAP) PR Newswire
Nov-26-19 12:48PM  Premium Millennial Generation Portfolio Yahoo Finance
Nov-08-19 11:53AM  Is Bio-Techne Corporation's (NASDAQ:TECH) CEO Paid Enough Relative To Peers? Simply Wall St.
Nov-07-19 07:00AM  Bio-Techne To Present At The 2019 Stifel Healthcare Conference PR Newswire
Nov-06-19 09:30AM  CELG vs. TECH: Which Stock Is the Better Value Option? Zacks
07:00AM  Bio-Techne Licenses aTAG Technology from C4 Therapeutics, Inc. PR Newswire
Nov-05-19 07:00AM  Bio-Techne To Present At The Stephens Nashville Investment Conference PR Newswire
Oct-31-19 12:38AM  Edited Transcript of TECH earnings conference call or presentation 29-Oct-19 1:00pm GMT Thomson Reuters StreetEvents
Oct-29-19 07:55AM  Techne (TECH) Q1 Earnings Lag Estimates Zacks
07:32AM  The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study Benzinga
06:30AM  Bio-Techne Releases First Quarter Fiscal 2020 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Oct-28-19 03:42PM  Bio-Techne will open $40M+ facility in St. Paul American City Business Journals
07:00AM  Bio-Techne Announces Investment For New GMP Manufacturing Facility PR Newswire
Oct-14-19 08:10PM  Hedge Funds Have Never Been More Bullish On Bio-Techne Corporation (TECH) Insider Monkey
Oct-10-19 02:23PM  Medicare Issues Final Local Coverage Decision For Bio-Techne's ExoDx Prostate(IntelliScore) Test PR Newswire
Oct-08-19 09:15AM  Bio-Techne To Host Conference Call On October 29, 2019, To Announce First Quarter 2020 Financial Results PR Newswire
Oct-07-19 09:15AM  Bio-Techne Leverages The RNAscope Technology To Advance A Multiomic Approach To Antibody Validation PR Newswire
Oct-02-19 02:05PM  Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet? Simply Wall St.
Oct-01-19 03:50PM  5 Health Care Stocks Held By Gurus GuruFocus.com
Sep-26-19 03:38PM  Mairs and Power Growth Fund 2nd-Quarter Shareholder Letter GuruFocus.com
Sep-16-19 09:15AM  Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility PR Newswire
Aug-28-19 05:48PM  Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2019 GuruFocus.com
Aug-27-19 06:07AM  Bio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five Years Simply Wall St.
Aug-23-19 07:16AM  5 Tips for Making Money in Penny Stocks InvestorPlace
Aug-20-19 09:15AM  Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice System PR Newswire
Aug-15-19 09:15AM  Bio-Techne To Present At The Baird 2019 Global Healthcare Conference PR Newswire
08:22AM  New Strong Sell Stocks for August 15th Zacks
Aug-13-19 09:15AM  Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay PR Newswire
Aug-10-19 02:50PM  Edited Transcript of TECH earnings conference call or presentation 6-Aug-19 1:00pm GMT Thomson Reuters StreetEvents
Aug-07-19 06:45AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Aug-06-19 06:23PM  Bio-Techne Corp (TECH) Q4 2019 Earnings Call Transcript Motley Fool
08:55AM  Techne (TECH) Q4 Earnings and Revenues Lag Estimates Zacks
06:30AM  Bio-Techne Releases Fourth Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Aug-05-19 01:36PM  Bio-Techne Corporation (NASDAQ:TECH): Earnings To Drop Next Year Simply Wall St.
Aug-02-19 11:46AM  Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2? Zacks
09:26AM  What's in Store for Cardinal Health (CAH) in Q4 Earnings? Zacks
Aug-01-19 11:55AM  Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store? Zacks
Jul-31-19 11:14AM  Can Patient Wins Aid GW Pharmaceuticals (GWPH) Q2 Earnings? Zacks
Jul-29-19 11:38AM  Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival? Zacks
Jul-25-19 07:33AM  Why Bio-Techne Corporation's (NASDAQ:TECH) High P/E Ratio Isn't Necessarily A Bad Thing Simply Wall St.
Jul-23-19 09:15AM  Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay PR Newswire
Jul-22-19 09:30AM  CBM or TECH: Which Is the Better Value Stock Right Now? Zacks
Jul-18-19 09:15AM  Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results PR Newswire
Jul-17-19 09:15AM  Bio-Techne Releases 32x8 Cartridge For The Ella Platform PR Newswire
Jul-16-19 07:01AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jul-11-19 09:15AM  Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues PR Newswire
Jul-09-19 10:10AM  Why the Earnings Surprise Streak Could Continue for Techne (TECH) Zacks
09:15AM  Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland PR Newswire
Jul-02-19 03:40PM  Baron Capital Commentary: Early Detection for the Win GuruFocus.com
01:53PM  At US$209, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely? Simply Wall St.
Jun-26-19 09:07AM  Bio-Techne China Recognized With "Decade of Contribution Award" PR Newswire
Jun-25-19 04:05PM  Bio-Techne Appoints Rupert Vessey to Board of Directors PR Newswire
Jun-21-19 09:15AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jun-18-19 10:19PM  Heres What Hedge Funds Think About Bio-Techne Corporation (TECH) Insider Monkey
04:15PM  Royce Funds Commentary: Lauren Romeo on 4 Quality Cyclicals GuruFocus.com
Jun-17-19 09:15AM  FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx Prostate IntelliScore (EPI) Test PR Newswire
Jun-13-19 04:35PM  Bio-Techne Receives Approval To Offer The ExoDx Prostate Intelliscore (EPI) Test In New York State PR Newswire
Jun-06-19 08:48AM  If You Like EPS Growth Then Check Out Bio-Techne (NASDAQ:TECH) Before It's Too Late Simply Wall St.
Jun-05-19 09:44AM  The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne Zacks
09:02AM  Myriad Genetics Announces Study Results Of myRisk Cancer Test Zacks
Jun-04-19 05:30PM  Bio-Techne To Acquire B-MoGen Biotechnologies Inc. PR Newswire
02:12PM  5 Biotech Stocks to Buy Right Now Zacks
Jun-03-19 09:08AM  Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference PR Newswire
May-28-19 09:15AM  Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics PR Newswire
May-21-19 09:30AM  CBM vs. TECH: Which Stock Is the Better Value Option? Zacks
09:08AM  Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference PR Newswire
May-14-19 02:10PM  Does Bio-Techne Corporation's (NASDAQ:TECH) Past Performance Indicate A Stronger Future? Simply Wall St.
09:08AM  Bio-Techne To Present At The UBS Global Healthcare Conference PR Newswire
May-06-19 07:00AM  Roche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis PR Newswire
May-02-19 11:46AM  Edited Transcript of TECH earnings conference call or presentation 30-Apr-19 1:00pm GMT Thomson Reuters StreetEvents
09:08AM  Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference PR Newswire
Apr-30-19 02:55PM  Bio-Techne Corp (TECH) Q3 2019 Earnings Call Transcript Motley Fool
06:30AM  Bio-Techne Releases Third Quarter Fiscal 2019 Results PR Newswire
06:30AM  Bio-Techne Declares Dividend PR Newswire
Apr-25-19 07:12AM  14 acquisitions later, Bio-Techne puts the checkbook away as growth unfolds American City Business Journals
Apr-23-19 10:32AM  Earnings Preview: Techne (TECH) Q3 Earnings Expected to Decline Zacks
Apr-22-19 01:07PM  Hedge Funds Dropped The Ball On Bio-Techne Corporation (TECH) Insider Monkey
09:15AM  Elpiscience and Bio-Techne Announce Strategic Collaboration PR Newswire
Apr-09-19 12:51PM  Are Bio-Techne Corporation's (NASDAQ:TECH) Interest Costs Too High? Simply Wall St.
09:07AM  Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results PR Newswire
Mar-28-19 09:09AM  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling PR Newswire
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment offers proteins and reagent solutions, including cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and T-Cell activation technologies. This segment also provides manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration -regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for original equipment manufacturers and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays comprising the ExoDx Prostate test for prostate cancer diagnosis. This segment also manufactures and sells tissue-based in-situ hybridization assays for research and clinical use. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HIGGINS JOHN LDirectorFeb 12Option Exercise61.465,000307,3009,021Feb 14 04:13 PM
HIGGINS JOHN LDirectorFeb 12Sale205.235,0001,026,1334,021Feb 14 04:13 PM
Kummeth Charles R.Chief Executive OfficerJan 06Option Exercise67.4610,276693,219140,265Jan 08 04:34 PM
Kummeth Charles R.Chief Executive OfficerJan 06Sale217.2810,2762,232,769129,989Jan 08 04:34 PM
Kummeth Charles R.Chief Executive OfficerJan 03Option Exercise67.467,999539,613137,988Jan 06 04:39 PM
Kummeth Charles R.Chief Executive OfficerJan 03Sale217.567,9991,740,240129,989Jan 06 04:39 PM
Kummeth Charles R.Chief Executive OfficerJan 02Option Exercise67.4619,8431,338,609149,832Jan 06 04:39 PM
Kummeth Charles R.Chief Executive OfficerJan 02Sale218.5919,8434,337,541129,989Jan 06 04:39 PM
Kummeth Charles R.Chief Executive OfficerDec 24Option Exercise67.4647131,774130,460Dec 27 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 24Sale222.18471104,648129,989Dec 27 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 23Option Exercise67.4665944,456130,648Dec 27 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 23Sale222.08659146,351129,989Dec 27 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 20Option Exercise67.465,767389,042135,756Dec 23 04:31 PM
Kummeth Charles R.Chief Executive OfficerDec 20Option Exercise67.465,767389,042135,756Dec 23 04:32 PM
Kummeth Charles R.Chief Executive OfficerDec 20Sale222.065,7671,280,632129,989Dec 23 04:32 PM
Kummeth Charles R.Chief Executive OfficerDec 20Sale222.065,7671,280,632129,989Dec 23 04:31 PM
Furlow Brenda S.SVP - General CounselDec 12Option Exercise94.358,000754,80010,711Dec 17 04:32 PM
Furlow Brenda S.SVP - General CounselDec 12Sale215.608,0001,724,7722,711Dec 17 04:32 PM
Kummeth Charles R.Chief Executive OfficerDec 10Option Exercise67.4670347,424136,459Dec 12 04:35 PM
Kummeth Charles R.Chief Executive OfficerDec 10Sale222.01703156,073135,756Dec 12 04:35 PM
WIENS HAROLD JDirectorDec 04Option Exercise87.832,000175,6607,221Dec 06 04:50 PM
WIENS HAROLD JDirectorDec 04Sale217.852,000435,6935,221Dec 06 04:50 PM
Kummeth Charles R.Chief Executive OfficerNov 29Sale222.6210022,262135,756Dec 02 04:22 PM
Kummeth Charles R.Chief Executive OfficerNov 27Option Exercise67.4611,772794,139147,628Dec 02 04:22 PM
Kummeth Charles R.Chief Executive OfficerNov 27Sale222.1211,7722,614,814135,856Dec 02 04:22 PM
Nusse RoelandDirectorNov 25Option Exercise60.7915,000911,90020,721Nov 29 11:35 AM
Nusse RoelandDirectorNov 25Sale219.338,3471,830,73112,374Nov 29 11:35 AM
Hippel JamesChief Financial OfficerNov 22Option Exercise94.3523,6512,231,47232,958Nov 25 04:25 PM
Hippel JamesChief Financial OfficerNov 22Sale215.5923,6515,098,9019,307Nov 25 04:25 PM
Hippel JamesChief Financial OfficerNov 21Option Exercise94.3511,3491,070,77820,656Nov 25 04:25 PM
Hippel JamesChief Financial OfficerNov 21Sale215.3611,3492,444,1329,307Nov 25 04:25 PM
Kummeth Charles R.Chief Executive OfficerSep 09Buy185.0020037,000100Sep 11 04:42 PM
Kummeth Charles R.Chief Executive OfficerAug 13Option Exercise67.467,410499,879110,877Aug 15 04:45 PM
BAUMGARTNER ROBERT VDirectorAug 07Buy191.0650095,5308,726Aug 09 04:12 PM
Kummeth Charles R.Chief Executive OfficerJul 10Option Exercise67.4616,9691,144,729109,145Jul 12 04:18 PM
Kummeth Charles R.Chief Executive OfficerJul 10Sale213.1216,9693,616,42892,176Jul 12 04:18 PM
Kummeth Charles R.Chief Executive OfficerJul 09Option Exercise67.4615,0371,014,396107,213Jul 10 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 09Sale212.4315,0373,194,34092,176Jul 10 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 08Option Exercise67.4617,9941,213,875110,170Jul 10 04:46 PM
Kummeth Charles R.Chief Executive OfficerJul 08Sale212.7517,9943,828,18492,176Jul 10 04:46 PM
Eansor Norman DavidSVP - Novus BiologicalsJun 12Sale215.003,117670,1550Jun 14 04:13 PM
HIGGINS JOHN LDirectorJun 04Option Exercise63.035,000315,1508,526Jun 06 04:30 PM
HIGGINS JOHN LDirectorJun 04Sale203.675,0001,018,3463,526Jun 06 04:30 PM
Furlow Brenda S.SVP - General CounselMay 24Option Exercise0.005,40007,589May 29 04:29 PM
Furlow Brenda S.SVP - General CounselMay 24Sale200.005,4001,080,0002,189May 29 04:29 PM
Hippel JamesChief Financial OfficerMay 01Option Exercise86.2535,0003,018,75039,382May 02 04:14 PM
Kelderman KimPresident, Diagnostics & GenomMay 01Option Exercise202.131,667336,9511,667May 02 04:18 PM
Hippel JamesChief Financial OfficerMay 01Sale203.0835,0007,107,6814,382May 02 04:14 PM